SCHEMBL6159554

SCHEMBL6159554

CCOC(=O)c1cc(C)c(Br)c([N+](=O)[O-])c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.53
NPC1 O15118 3/20 0.52
ALDH1A1 P00352 5/20 0.52
MAPT P10636 4/20 0.52
RAB9A P51151 3/20 0.52
PKM P14618 2/20 0.52
CRHBP P24387 1/20 0.52
CRHR2 Q13324 1/20 0.52
LMNA P02545 2/20 0.51
POLB P06746 2/20 0.51
KDM4E B2RXH2 2/20 0.51
PTGER4 P35408 1/20 0.49
ESR1 P03372 1/20 0.49
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46
CA14 Q9ULX7 1/20 0.46
SMN1; SMN2 Q16637 4/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10487618 0.90 ESR1 (0.55) KMT2ANPC1ALDH1A1MAPTRAB9A
SCHEMBL10487703 0.87 KMT2A (0.52) KMT2ANPC1ALDH1A1MAPTRAB9A
SCHEMBL4199372 0.85 VCAM1 (0.50) KMT2AALDH1A1MAPTPKMLMNA
SCHEMBL13011084 0.84 ESR1 (0.60) KMT2ANPC1ALDH1A1MAPTRAB9A
SCHEMBL10487679 0.83 ALDH1A1 (0.51) KMT2ANPC1ALDH1A1MAPTRAB9A
SCHEMBL6815909 0.83 KMT2A (0.59) KMT2ANPC1ALDH1A1MAPTRAB9A
SCHEMBL14879728 0.82 KMT2A (0.48) KMT2ANPC1ALDH1A1MAPTRAB9A
SCHEMBL10606064 0.82 KMT2A (0.53) KMT2ANPC1ALDH1A1MAPTRAB9A
SCHEMBL25276513 0.82 CA12 (0.60) NPC1ALDH1A1LMNAESR1CA12
SCHEMBL5924443 0.81 ESR1 (0.69) KMT2ANPC1ALDH1A1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013059648-A1 2,3,5 TRISUBSTITUTED ARYL AND HETEROARYL AMINO DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2013-04-25 WO disclosed
EP-1178969-B1 GASTRIN AND CHOLECYSTOKININ RECEPTOR LIGANDS BLACK JAMES FOUNDATION (GB) 2005-07-13 EP disclosed
US-6479531-B1 Gastrin and cholecystokinin receptor ligands JAMES BLACK FOUNDATION LIMITED (GB) 2002-11-12 US disclosed
EP-1178969-A1 GASTRIN AND CHOLECYSTOKININ RECEPTOR LIGANDS JAMES BLACK FOUNDATION LIMITED (GB) 2002-02-13 EP disclosed
WO-2000027823-A1 GASTRIN AND CHOLECYSTOKININ RECEPTOR LIGANDS JAMES BLACK FOUNDATION LIMITED (GB) 2000-05-18 WO disclosed
EP-0206635-B1 PREPARATION OF 3-AMINO-4-HYDROXYBENZOIC ACIDS THE DOW CHEMICAL COMPANY (US) 1989-11-15 EP disclosed
US-4835306-A Preparation of 3-amino-4-hydroxybenzoic acids THE DOW CHEMICAL COMPANY (US) 1989-05-30 US disclosed
EP-0206635-A1 Preparation of 3-amino-4-hydroxybenzoic acids THE DOW CHEMICAL COMPANY (US) 1986-12-30 EP disclosed